Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort BXiuning Le, Paul K. Paik, Luis Paz‐Ares et al.|Cell Reports Medicine|2023Cited by 18
EE146 Cost-effectiveness of Tepotinib for Patients With Previously Treated Advanced Non-Small Cell Lung Cancer Harboring Metex14 Skipping Alterations in SpainEdurne Arriola, H. Wheat, H. Vioix et al.|Value in Health|2023Cited by 0